Bicara Therapeutics Inc.

BCAX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $1.5B · 103 employees
33
SEC Filings
$22.01
Close 2026-09-21
103
Employees

Business Summary

Bicara Therapeutics is a clinical-stage biopharmaceutical company developing bifunctional therapies for solid tumors. Its lead program, ficerafusp alfa (formerly BCA101), is a bifunctional EGFR-directed monoclonal antibody fused to a TGF-beta ligand trap. The company is conducting a global Phase 2/3 pivotal trial (FORTIFI-HN01) evaluating ficerafusp alfa in combination with pembrolizumab in first-line recurrent/metastatic HPV-negative head and neck squamous cell carcinoma.

Latest Stock Quote

BCAX 2026-09-21 $22.01 O:$23.06 H:$23.34 L:$21.95 Vol:0.3M VWAP:$22.2466
origin leaf: null

Next Earnings

expected 2026-11-24

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001628280-26-022010EDGAR92K words
2025-03-272024-12-310002023658-25-000012EDGAR96K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-112026-06-300001628280-26-055765EDGAR66K words
2025-11-102025-09-300002023658-25-000109EDGAR63K words
2025-08-122025-06-300002023658-25-000098EDGAR61K words
2025-05-132025-03-310002023658-25-000039EDGAR59K words
2024-11-122024-09-300002023658-24-000002EDGAR66K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-250001628280-26-058937EDGAR9K words
2026-08-110001628280-26-055500EDGAR3K words
2026-07-280001628280-26-049937EDGAR1K words
2026-03-300001628280-26-021868EDGAR3K words
2026-02-260001193125-26-076560EDGAR20K words
2026-02-190001628280-26-009808EDGAR2K words
2026-01-120001628280-26-001766EDGAR0K words
2025-12-080002023658-25-000112EDGAR1K words
2025-11-100002023658-25-000107EDGAR3K words
2025-08-120002023658-25-000094EDGAR2K words

33 total filings indexed. 16 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

head-and-neck-squamous-cell-carcinoma-(hnscc) solid-tumors recurrent/metastatic-hpv-negative-hnscc squamous-cell-carcinomas

Company Identity

CIK0002023658
TickerBCAX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.bicara.com
Listed2024-09-13

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: eb7ee66ee2831e5551056a4cc49c05405bba9f38814a0927131a7fb3cce72a34
parent: 2a1b814bbfdc80b0acd71708862d407e8458057e667968d68a4b3ecaebd9f927
content hash: a6f82119f10446a6982549bc36a9a3f3292983f9e09710cb40ab833da292e2ec
signed: 2026-09-28T19:00:27.528Z
sources: 7 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up BCAX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on BCAX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/BCAX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.